Live feed06:45:00·422dPRReleasevia QuantisnowProtagonist and Takeda Announce Positive Topline Results from Phase 3 VERIFY Study of Rusfertide in Patients with Polycythemia VeraByQuantisnow·Wall Street's wire, on your screen.PTGX· Protagonist Therapeutics Inc.TAK· Takeda Pharmaceutical Company LimitedHealth Care
